B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

OXER1

MOLECULAR TARGET

oxoeicosanoid receptor 1

UniProt: Q8TDS5NCBI Gene: 1651401 compounds

OXER1 (oxoeicosanoid receptor 1) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting OXER1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Dehydroepiandrosterone Sulfate0.691

About OXER1 as a Drug Target

OXER1 (oxoeicosanoid receptor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented OXER1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

OXER1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.